These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

889 related items for PubMed ID: 28615366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, Savarese G, Lam CSP, Lund LH.
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G, Vedin O, D'Amario D, Uijl A, Dahlström U, Rosano G, Lam CSP, Lund LH.
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [Abstract] [Full Text] [Related]

  • 4. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I, Szummer K, Dahlström U, Jernberg T, Lund LH.
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G, Ghionzoli N, Innocenti L, Taddei C, Giannoni A, Valleggi A, Borrelli C, Senni M, Passino C, Emdin M.
    J Am Heart Assoc; 2019 Oct 15; 8(20):e013441. PubMed ID: 31587602
    [Abstract] [Full Text] [Related]

  • 7. Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.
    Teng TK, Tay WT, Dahlstrom U, Benson L, Lam CSP, Lund LH.
    Int J Cardiol; 2018 Mar 01; 254():203-209. PubMed ID: 29407092
    [Abstract] [Full Text] [Related]

  • 8. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
    Lund LH, Claggett B, Liu J, Lam CS, Jhund PS, Rosano GM, Swedberg K, Yusuf S, Granger CB, Pfeffer MA, McMurray JJV, Solomon SD.
    Eur J Heart Fail; 2018 Aug 01; 20(8):1230-1239. PubMed ID: 29431256
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
    Savarese G, Jonsson Å, Hallberg AC, Dahlström U, Edner M, Lund LH.
    Int J Cardiol; 2020 Jan 01; 298():59-65. PubMed ID: 31521440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
    Chen X, Savarese G, Dahlström U, Lund LH, Fu M.
    Clin Res Cardiol; 2019 Dec 01; 108(12):1394-1405. PubMed ID: 30980205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
    Savarese G, Orsini N, Hage C, Dahlström U, Vedin O, Rosano GMC, Lund LH.
    J Card Fail; 2018 Jun 01; 24(6):365-374. PubMed ID: 29597053
    [Abstract] [Full Text] [Related]

  • 14. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y, Watanabe E, Lip GYH, Koshikawa M, Ichikawa T, Kawai M, Harada M, Inamasu J, Ozaki Y.
    Heart Vessels; 2018 Apr 01; 33(4):403-412. PubMed ID: 29067492
    [Abstract] [Full Text] [Related]

  • 15. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D, Simitsis P, Bistola V, Triposkiadis F, Ikonomidis I, Katsanos S, Bakosis G, Hatziagelaki E, Lekakis J, Mebazaa A, Parissis J.
    Clin Res Cardiol; 2017 May 01; 106(5):359-368. PubMed ID: 27999929
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, Mebazaa A, Lund L, Ambrosio GA, Coats AJ, Ferrari R, Ruschitzka F, Maggioni AP, Filippatos G.
    Eur J Heart Fail; 2017 Dec 01; 19(12):1574-1585. PubMed ID: 28386917
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.